The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines Philip ArlenKwong-Yok TsangJ. Michael Hamilton ORIGINAL ARTICLE Pages: 517 - 529
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival Michele OrdituraCiro RomanoGiuseppe Catalano ORIGINAL ARTICLE Pages: 530 - 536
Granulocyte/macrophage-colony-stimulating factor augments lymphokine-activated killer activity from lymphocytes via macrophages in lung cancer patients Keiji TakahashiSeiya SaitoYasumasa Monden ORIGINAL ARTICLE Pages: 537 - 543
Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability Lorenzo PiemontiPaolo MontiValerio Di Carlo ORIGINAL ARTICLE Pages: 544 - 550
Targeting of cancer cells with monoclonal antibodies specific for C3b(i) Mitchell H. SokoloffAlessandra NardinRonald P. Taylor ORIGINAL ARTICLE Pages: 551 - 562
Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon γ: its role in the elicitation of an effective antitumor immune response M. Divya JyothiAshok Khar ORIGINAL ARTICLE Pages: 563 - 572